This campaign has now closed
To find a new, more effective treatment for ovarian cancer to improve women's chances of survival.
Categories
Beneficiaries
Situation
59% of women with ovarian cancer will die within 5 years of diagnosis. The survival rates are so low, because many women develop a resistance to conventional chemotherapy.
Solution
Predicting which women will develop a resistance to chemotherapy, will mean that alternative treatments can be given. This project will investigate the role of a particular protein (LARP1), that has the ability to make cancer cells 'turn nasty'.